Related Experiment Video
Updated: Feb 6, 2026

Profiling Voltage-gated Potassium Channel mRNA Expression in Nigral Neurons using Single-cell RT-PCR Techniques
Published on: September 27, 2011
Inhibition of hyperpolarization-activated cyclic nucleotide-gated channels by β-blocker carvedilol
Ying Cao1, Shujun Chen1, Yemei Liang1
1Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Insights
Carvedilol inhibits hyperpolarization-activated cyclic nucleotide (HCN) channels, particularly HCN4, which may explain its benefits in heart failure. This finding offers a novel structure for developing new HCN channel inhibitors.
Area of Science:
- Cardiovascular Pharmacology
- Ion Channel Physiology
Background:
- Carvedilol is a beta-blocker effective for congestive heart failure (CHF).
- The mechanism of carvedilol's superior efficacy in CHF is unclear.
- Hyperpolarization-activated cyclic nucleotide (HCN)-gated channels are crucial for heart rate regulation and potential CHF treatments.
Purpose of the Study:
- To investigate the effect of carvedilol on HCN channels.
- To determine if carvedilol modulates HCN channel activity.
Main Methods:
- Whole-cell patch-clamp recordings were used.
- Carvedilol's effects were assessed on wild-type and mutant HCN1, HCN2, and HCN4 channels expressed in CHO cells.
Main Results:
- Carvedilol selectively inhibited the sinoatrial HCN channel isoform, HCN4, in a concentration-dependent manner (EC50 = 4.4 μM).
- Carvedilol also inhibited HCN1 and HCN2 channels.
- Carvedilol acts as a negative gating modulator, slowing activation and deactivation rates, and shifting voltage dependence, distinguishing it from open-channel blockers like ivabradine.
Conclusions:
- Carvedilol negatively modulates HCN channel gating.
- This action on HCN channels provides a novel mechanism for carvedilol's therapeutic effects in CHF.
- Carvedilol's interaction with HCN channels presents a new structural basis for designing future HCN channel inhibitors.
Background And Purpose:
Carvedilol is a clinically effective β-blocker broadly used for treating congestive heart failure (CHF), and several clinical trials have demonstrated that it shows a favourable effect compared with other β-blockers in patients with CHF. The mechanism underlying this beneficial effect of carvedilol compared to other β-blockers is not clearly understood. In addition to β-blockers, inhibitors of hyperpolarization-activated cyclic nucleotide (HCN)-gated channels, which play a critical role in spontaneous rhythmic activity in the heart, have also been proposed to be suitable drugs for reducing heart rate and, therefore, beneficial for treating CHF. In the present study, we investigated the effect of carvedilol on HCN channels.
Experimental Approach:
Whole-cell patch-clamp recordings were used to assess the effect of carvedilol on currents from wild-type and mutant HCN1, HCN2 and HCN4 channels expressed in CHO cells.
Key Results:
Carvedilol was the only β-blocker tested that showed inhibitory effects on the major sinoatrial HCN channel isoform HCN4. Carvedilol inhibited HCN4 in a concentration-dependent manner with an EC50 of 4.4 μM. In addition, carvedilol also inhibited HCN1 and HCN2 channels. Carvedilol blocked HCN channels by decelerating the rate of channel activation and increasing that of deactivation, and shifted the voltage-dependence of activation leftwards. Our data also showed that carvedilol, unlike other inhibitors of this channel (ivabradine and ZD7288), is not an 'open-channel' inhibitor of HCN4.
Conclusions And Implications:
Carvedilol is a negative gating modulator of HCN channels. It represents a novel structure for future drug design of HCN channel inhibitors.
Related Concept Videos
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Mechanically-gated Ion Channels
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
G-Protein Gated Ion Channels
Sensory...
Ligand-Gated Ion Channel Receptor: Gating Mechanism

